Skip to content

Avalyn Pharma Inc.

AVLN· NasdaqCore metricsCIK 1540171

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.12%
Market cap
$1.36B
44.52M shares
Filings
67
—
—
—
-$29.66M
Q3 2026
—
-$33.09M
Q3 2026
—
-$82.90M
Q3 2026derived
—
-$0.67
Q3 2026
—
$145.42M
Q3 2026+118.4% FY25 yoy
$1.36B
—
—
3.7×
—
—

FY2026 figures · derived

Price

$30.59+3.71%+$1.10since Apr 30, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Total Interest and Dividend Income

$3.76MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Avalyn Pharma Inc. is the 126th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Avalyn Pharma Inc. · CIK 1540171 · Engraved from SEC EDGAR